Tag: Boston Scientific

Boston’s WaveWriter SCS systems gain expanded non-surgical back pain indication from...

Boston Scientific Corporation announced today that the US Food and Drug Administration (FDA) has approved an expanded indication of the company’s WaveWriter spinal cord...

Boston Scientific announces positive WaveWriter SCS findings from SOLIS trial

Boston Scientific Corporation has announced positive one-year results from the SOLIS randomised controlled trial, demonstrating sustained pain relief using its WaveWriter Alpha spinal cord...

Boston Scientific expands neuromodulation portfolio with Relievant Medsystems acquisition

Boston Scientific Corporation has announced the close of its acquisition of Relievant Medsystems—the company behind the US Food and Drug Administration (FDA)-cleared Intracept intraosseous...

Boston receives expanded US FDA approval of SCS therapy for painful...

Boston Scientific has announced that the US Food and Drug Administration (FDA) has approved an expanded indication of the WaveWriter Alpha spinal cord stimulator...

Boston Scientific to expand neuromodulation portfolio with Relievant Medsystems acquisition

Boston Scientific Corporation has today announced it has entered into a definitive agreement to acquire Relievant Medsystems—a privately held medical technology company that has...

Boston Scientific announces three-month data from SOLIS trial at NANS

Combination spinal cord stimulation (SCS) therapy with Boston Scientific’s WaveWriter system has demonstrated superior outcomes to conventional medical management (CMM) in chronic pain patients...

Multiple-modality spinal cord stimulation demonstrates sustained improvement in chronic pain outcomes

A spinal cord stimulation (SCS) system capable of simultaneously delivering multiple treatment modalities has produced a sustained improvement in outcomes in a randomised controlled...

WaveWriter Alpha Spinal Cord Stimulator System wins Best Overall Medical Device...

The WaveWriter Alpha Spinal Cord Stimulator (SCS) System (Boston Scientific) has been named Best Overall Medical Device Solution at the fifth annual MedTech Breakthrough...

WaveWriter Alpha SCS systems launches in USA

Boston Scientific has announced that its WaveWriter Alpha spinal cord stimulation (SCS) systems will have a limited market release in the USA. The SCS...

Boston Scientific closes acquisition of Vertiflex

Boston Scientific has announced the close of its acquisition of Vertiflex, a privately-held company that developed and commercialised the Superion Indirect Decompression System, a minimally-invasive...